RecruitingNot ApplicableNCT06687122

Egg Intake, Metabolic Outcomes and Choline Levels

Additional Daily Intake of Eggs for Improving Metabolic Outcomes and Choline Levels in Individuals With Obesity: Phase I Study


Sponsor

University of Guelph

Enrollment

20 participants

Start Date

Jan 24, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this research is to determine the effect of additional daily egg intake on metabolic phenotypes and metabolism in the context of obesity.


Eligibility

Min Age: 30 YearsMax Age: 65 Years

Inclusion Criteria6

  • Male or female participant of any race or ethnicity between 30-65 (inclusive) years of age
  • BMI > 30 kg/m2
  • Non-smoker
  • Willing to consume 3 eggs per day for one dietary period of 4 weeks
  • Willing to avoid eggs during the rest of the study except for eggs that are provided
  • Willing to follow the study protocol including maintaining usual lifestyle during the entire study

Exclusion Criteria6

  • Age < 30 or > 65 years
  • BMI < 30 kg/m2
  • Vegans or individuals who do not consume eggs
  • Individuals who are currently pregnant or planning to become pregnant during the course of the study; or are currently breastfeeding
  • Smokers, users of recreational drugs
  • Individuals taking antibiotics or natural health products including prebiotics or probiotics

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENT3 whole eggs

Participants will be free-living and will not be supplied with any other food except for the eggs during the intervention period with no restrictions of energy intake.


Locations(1)

Research Center of the Institut universitaire de cardiologie et de pneumologie de Québec - ULaval

Québec, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06687122


Related Trials